Global Flow Cytometry Market Assessment, By Products and Service [Instruments, Kits and Reagents, Software and Services, Others], By Technology [Cell-based Flow Cytometry, Bead-based Flow Cytometry], By Application [Oncology, Drug Discovery, Stem Cell Therapy, Hematology, Immunology, Other Applications], By End-user [Hospitals, Clinical Testing Laboratories, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 9.2 billion in 2031.
Home>Industry Reports>Global Flow Cytometry Market Assessment, Opportunities and Forecast, 2017-2031F
Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 9.2 billion in 2031. The increasing geriatric population and the rising prevalence of chronic and infectious diseases drive growth in the global flow cytometry market. Flow cytometry is a powerful tool with applications in multiple disciplines such as immunology, virology, molecular biology, cancer biology, and infectious disease monitoring. Moreover, increasing healthcare expenditure on research and development for the development of the latest technologies and products is further expected to drive the market.
Technological advancements and new product launches in flow cytometry have significantly impacted the industry. One notable development is various companies' commercial launch of spectral flow cytometry technology. These advancements are crucial in addressing the increasing prevalence of diseases, such as cancer, immunodeficiency disorders, and infectious diseases. They are expected to play a vital role in personalized medicine, drug discovery, and development. However, the high cost of advanced flow cytometry equipment remains challenging, potentially limiting accessibility for smaller research facilities or emerging countries. Moreover, government initiatives for improving access to these technologies in developing and under-developed countries, the presence of several leading players, and ongoing partnerships between public and private companies for engineering advanced flow cytometry devices and instruments are facilitating market growth.
Increasing Prevalence of Chronic and Infectious Diseases
There has been a surge in the demand for flow cytometry due to the rising number of chronic and infectious diseases worldwide. Flow cytometry plays a crucial role in detecting and analyzing diseases such as cancer, HIV, AIDS, TB, and many more. Rising awareness among healthcare professionals regarding the accuracy and sensitivity of flow cytometry is contributing to industry growth.
According to WHO 2023 statistics, chronic diseases are responsible for 41 million deaths every year at a global level. This affects people of all age groups, irrespective of their region or country. A sedentary lifestyle, unhealthy diet, and excessive tobacco and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases. Early diagnosis, accurate detection, and early intervention of the disease and its disease-causing agents are the only solutions to combat the growing prevalence of chronic diseases. This, in turn, enables healthcare professionals to use advanced technologies and highly efficient testing options, such as flow cytometry, acting as a major growth-inducing factor.
Technological Advancements
With a high prevalence of cancer, AIDS, and many other infectious diseases, there is an increasing demand to bring innovation in the flow cytometry industry that can enhance the accuracy of diagnosis and gather insights related to cell structure and functions. Key players are constantly investing in research and development to launch innovative products and instruments to facilitate flow cytometry technological advancements. In June 2023, Becton, Dickinson and Company, a global leader in medical technology, announced that it has launched an innovative automated instrument “BD FACSDuet”, that can prepare samples for clinical diagnostics using flow cytometry to improve standardization and reproducibility in cellular diagnostics. The entire sample preparation process, including cocktailing, washing, and centrifuging, is automated by this product. These samples are then transferred to the physically integrated BD FACSLyric clinical flow cytometry system without any human intervention.
Government Initiatives
Government initiatives are playing a significant role in supporting the field of flow cytometry. One notable example is the establishment of the NIST Flow Cytometry Standards Consortium, which brings together industry, academia, and government to identify and address measurement and standard needs across the flow cytometry field. Additionally, government support through funds, grants, and public-private partnerships is contributing to the growth of the flow cytometry market, particularly in the context of research activities such as cancer, stem cell, and HIV studies. These initiatives are crucial in advancing the field of flow cytometry and addressing standardization issues, ultimately contributing to the development of new and innovative technologies in the market.
In August 2022, NanoCellect Biomedical Inc., a leader in developing and manufacturing microfluidic cells, announced that it received a grant of USD 1.8 million from Small Business Innovation Research (SBIR). This fund was granted to assist NanoCellect Biomedical Inc. in developing AI-based imaging flow cytometry technology. It would further help in research programs to develop novel imaging flow cytometry technology.
Growth in Demand for Cell Based Flow Cytometry
Among the technology segment, cell-based flow cytometry segment is expected to grow faster. Cell-based flow cytometry offers the advantage of high throughput and the potential to analyze millions of cells. Flow cytometry provides highly detailed information on single cells for immunotherapy clinical trials, enabling the monitoring of immune responses and the detection of abnormal cells. This technology monitors changes in immune cell phenotype, tracks therapeutic cells, and detects abnormal cells, thus offering a comprehensive view of a disease's micro-environment. In May 2023, Becton, Dickinson and Company, announced global commercial launch of an innovative cell sorting instrument, “BD FACSDiscover”, a cell-based technology that will enable researchers to get more insights about cells in various areas, such as drug discovery, immuno-oncology and genomics, which is not possible in traditional flow cytometry experiments. BD FACSDiscover allows the investigation of different aspects of single-cell biology and sorts complex phenotypes for immunologic or genetic discovery.
North America Accounts for the Largest Share in Flow Cytometry Market
North America accounted for the largest share of the global flow cytometry market in 2022, with the United States being a major contributor to this dominance. The region's favorable business environment, substantial government support through funds and grants, and a robust healthcare infrastructure have driven its leadership in the flow cytometry market. Additionally, the high prevalence of HIV/AIDS and cancer has led to a growing focus on the development of treatment options for these target diseases, further propelling the demand for flow cytometry technologies.
The strong presence of key regional players, such as BD, Danaher Corporation, and Thermo Fisher Scientific, has also contributed to North America's market leadership. According to the CDC (Center for Disease Control), 6 out of 10 adults in the US are affected by a chronic disease, whereas 4 out of 10 adults in the USA have 2 or more chronic diseases. Thus, the significant prevalence of chronic and infectious diseases in this region will contribute to increased demand for rapid detection and diagnosis by flow cytometry.
Future Outlook of Global Flow Cytometry Market
Global flow cytometry market is expected to grow in the coming years, due to the growing elderly population and the increasing prevalence of infectious and chronic diseases globally. Technological advancements, research and development, government support, increasing healthcare budget, and collaborative ventures involving medical devices manufacturers, research institutions, and other healthcare providers are anticipated to drive the market growth over the forecasted period.
Report Scope
“Global Flow Cytometry Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global cytometry market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031 |
|
Projected Growth Rate |
CAGR of 7.89% between 2024-2031 |
|
Revenue Forecast in 2031 |
USD 9.2 billion |
|
Segments Covered |
Product and Services, Technology, Application, End-user |
|
Regions Covered |
North America, South America, Europe, Asia-Pacific, Middle East and Africa |
|
Key Companies Profiled |
Becton, Dickinson and Company, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec B.V. & Co. KG, Sysmex Asia Pacific Pte Ltd., Agilent Technologies, Inc., Sony Biotechnology Inc. LLC, Enzo Life Sciences, Inc., Cytek Biosciences, Inc., Sartorius AG, Apogee Flow Systems Ltd., Luminex Corporation |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global flow cytometry market has been segmented into the following categories:
· By Product and Service
o Instruments
§ Cell Analysers
§ Cell Sorters
o Kits and Reagents
o Software and Services
o Others
· By Technology
o Cell-based Flow Cytometry
o Bead-based Flow Cytometry
· By Application
o Oncology
o Drug Discovery
o Stem Cell Therapy
o Hematology
o Immunology
o Other Applications
· By End-user
o Hospitals
o Clinical Testing Laboratories
o Academic & Research Institutes
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
In the flow cytometry market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global market. These alliances empower firms to adapt to each other’s strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product developments, and contribute to the development and growth of the global flow cytometry market. In February 2023, Luminex Corporation signed an agreement to sell all its flow cytometry & imaging (FCI) business unit assets to Cytek Biosciences. With this strategic acquisition, the company would gain insights into all facets of cellular phenotypes and morphology. There are more than 7,000 instruments, which will be under the Cytek umbrella following this acquisition that will further expand the company’s global presence.
Key Players Operating in the Global Flow Cytometry Market are:
· Becton, Dickinson and Company
· Thermo Fisher Scientific
· Bio-Rad Laboratories, Inc.
· Miltenyi Biotec B.V. & Co. KG
· Sysmex Asia Pacific Pte Ltd.
· Agilent Technologies, Inc.
· Sony Biotechnology Inc. LLC
· Enzo Life Sciences, Inc.
· Cytek Biosciences, Inc.
· Sartorius AG
· Apogee Flow Systems Ltd.
· Luminex Corporation
Markets and Data’s reports answer the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global flow cytometry market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Flow Cytometry Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.Value
4.1.2.Volume
4.2. By Products and Service
4.2.1.Instruments
4.2.1.1. Cell Analysers
4.2.1.2. Cell Sorters
4.2.2.Kits and Reagents
4.2.3.Software and Services
4.2.4.Others
4.3. By Technology
4.3.1.Cell-based Flow Cytometry
4.3.2.Bead-based Flow Cytometry
4.4. By Application
4.4.1.Oncology
4.4.2.Drug Discovery
4.4.3.Stem Cell Therapy
4.4.4.Hematology
4.4.5.Immunology
4.4.6.Other applications
4.5. By End-user
4.5.1.Hospitals
4.5.2.Clinical Testing Laboratories
4.5.3.Academic & Research Institutes
4.5.4.Others
4.6. By Region
4.6.1.North America
4.6.2.Europe
4.6.3.South America
4.6.4.Asia-Pacific
4.6.5.Middle East and Africa
4.7. By Company Market Share (%), 2023
5. Global Flow Cytometry Market Outlook, By Region, 2017-2031F
5.1.1.1. Value
5.1.1.2. Volume
5.1.2.By Product and Services
5.1.2.1. Instruments
5.1.2.1.1. Cell Analysers
5.1.2.1.2. Cell Sorters
5.1.2.2. Kits and Reagents
5.1.2.3. Software and Services
5.1.2.4. Others
5.1.3.By Technology
5.1.3.1. Cell-based Flow Cytometry
5.1.3.2. Bead-based Flow Cytometry
5.1.4.By Application
5.1.4.1. Oncology
5.1.4.2. Drug Discovery
5.1.4.3. Stem Cell Therapy
5.1.4.4. Hematology
5.1.4.5. Immunology
5.1.4.6. Other applications
5.1.5.By End-user
5.1.5.1. Hospitals
5.1.5.2. Clinical Testing Laboratories
5.1.5.3. Academic & Research Institutes
5.1.5.4. Others
5.1.6.United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. Value
5.1.6.1.2. Volume
5.1.6.2. By Product and Services
5.1.6.2.1. Instruments
5.1.6.2.1.1. Cell Analysers
5.1.6.2.1.2. Cell Sorters
5.1.6.2.2. Kits and Reagents
5.1.6.2.3. Software and Services
5.1.6.2.4. Others
5.1.6.3. By Technology
5.1.6.3.1. Cell-based Flow Cytometry
5.1.6.3.2. Bead-based Flow Cytometry
5.1.6.4. By Application
5.1.6.4.1. Oncology
5.1.6.4.2. Drug Discovery
5.1.6.4.3. Stem Cell Therapy
5.1.6.4.4. Hematology
5.1.6.4.5. Immunology
5.1.6.4.6. Other applications
5.1.6.5. By End-user
5.1.6.5.1. Hospitals
5.1.6.5.2. Clinical Testing Laboratories
5.1.6.5.3. Academic & Research Institutes
5.1.6.5.4. Others
5.1.7.Canada
5.1.8.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. South America
5.3.1.Brazil
5.3.2.Argentina
5.4. Asia-Pacific
5.4.1.India
5.4.2.China
5.4.3.Japan
5.4.4.Australia
5.4.5.Vietnam
5.4.6.South Korea
5.4.7.Indonesia
5.4.8.Philippines
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Product and Services
6.2. By Technology
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Becton, Dickinson and Company
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Thermo Fisher Scientific
13.3. Bio-Rad Laboratories, Inc.
13.4. Miltenyi Biotec B.V. & Co. KG
13.5. Sysmex Asia Pacific Pte Ltd.
13.6. Agilent Technologies, Inc.
13.7. Sony Biotechnology Inc. LLC
13.8. Enzo Life Sciences, Inc.
13.9. Cytek Biosciences, Inc.
13.10. Sartorius AG
13.11. Apogee Flow Systems Ltd.
13.12. Luminex Corporation
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figure:
Figure 1. Global Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 4. Global Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 5. Global Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 6. Global Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 7. Global Flow Cytometry Market Share (%), By Region, 2017-2031F
Figure 8. North America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 11. North America Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 12. North America Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 13. North America Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 14. North America Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 15. United States Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 18. United States Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 19. United States Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 20. United States Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 24. Canada Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 25. Canada Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 26. Canada Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 30. Mexico Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 31. Mexico Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 36. Europe Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 37. Europe Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 38. Europe Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 40. Germany Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 43. Germany Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 44. Germany Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 45. Germany Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 46. France Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 49. France Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 50. France Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 51. France Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 55. Italy Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 56. Italy Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 57. Italy Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 61. United Kingdom Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 62. United Kingdom Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 67. Russia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 68. Russia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 69. Russia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 73. Netherlands Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 74. Netherlands Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 79. Spain Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 80. Spain Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 81. Spain Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 85. Turkey Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 86. Turkey Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 91. Poland Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 92. Poland Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 93. Poland Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 94. South America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 97. South America Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 98. South America Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 99. South America Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 100. South America Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 104. Brazil Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 105. Brazil Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 110. Argentina Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 111. Argentina Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 116. Asia-Pacific Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 117. Asia-Pacific Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 120. India Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 123. India Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 124. India Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 125. India Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 126. China Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 129. China Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 130. China Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 131. China Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 135. Japan Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 136. Japan Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 137. Japan Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 141. Australia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 142. Australia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 143. Australia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 147. Vietnam Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 148. Vietnam Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 153. South Korea Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 154. South Korea Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 159. Indonesia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 160. Indonesia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 165. Philippines Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 166. Philippines Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 171. Middle East & Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 172. Middle East & Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 178. Saudi Arabia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 179. Saudi Arabia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 184. UAE Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 185. UAE Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 186. UAE Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 190. South Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 191. South Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 193. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
LIST OF TABLE: GLOBAL FLOW CYTOMETRY MARKET
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the major factors influencing the growth of the global flow cytometry market?
Who are the key players operating in the global flow cytometry market?
What are the regions covered in the final report for the global flow cytometry market?
What is the market size and growth rate of the global flow cytometry market?
See Related Reports
Global Bone Densitometers Market Assessment, Opportunities and Forecast, 2017-2031F
There is an increased demand for dual-energy x-ray absorptiometry (DXA) in the global bone densitometers market. Also, increasing prevalence of osteoporosis, growing geriatric population, technological advancements, and collaborative research and new....Read More
Published on
May 2024
4,500
Global Medical Terminology Software Market Assessment, Opportunities and Forecast, 2017-2031F
Global medical terminology software market is expected to witness significant growth over the forecast period owing to an increase in measures for reducing clinical errors and rising investments towards the development of technologically advanced sol....Read More
Published on
May 2024
4,500
Global Legionella Testing Market Assessment, Opportunities and Forecast, 2017-2031F
Global legionella testing market will witness significant growth owing to the rapid expansion of the healthcare sector, increasing awareness about the importance of regular legionella testing, and rising prevalence of legionella related illnesses.....Read More
Published on
May 2024
4,500
Global Endoluminal Suturing Devices Market Assessment, Opportunities and Forecast, 2017-2031F
Global endoluminal suturing devices market is expected to witness significant growth over the forecast period owing to rise in the number of cases of gastrointestinal cancer and increasing preference for non-invasive procedures.....Read More
Published on
May 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
